TNFSF13B

Across TCGA pan-cancer cohorts, TNFSF13B mass-spec protein is linked to patient survival in 2 of 34 cancer types, making it a survival-associated TNFSF13B data layer compared with 25 for mass-spec protein and 4 for mutation status.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher TNFSF13B mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated TNFSF13B expression acts as an unfavorable survival marker.

COAD and PDAC are the cancer types where TNFSF13B mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	DFS	Median	II,III,IV	0.912	1.000	.035	24	view →
PDAC	OS	Median	All	0.238	0.681	.008	7	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

TNFSF13B–COAD (DFS)

Open the COAD breakdown →